Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang

Molecular Biology Reports

Volumn 38, Issue 5, 2011, Pages 3261-3269

  Liu, Zan ^a   Feng, Jun Guo ^a   Tuersun, Aerziguli ^a   Liu, Tao ^a   Liu, Hui ^a   Liu, Qing ^a   Zheng, Shu Tao ^a   Huang, Cong Gai ^a   Lv, Guo Dong ^a   Sheyhidin, Ilyar ^a   Lu, Xiao Mei ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Cathepsin D; Esophageal cancer; Kazakh; PKM2; Proteomics

Indexed keywords

ACTB PROTEIN; ADENYLATE KINASE; ADENYLATE KINASE 1; BINDING PROTEIN; CATECHOL METHYLTRANSFERASE; CATHEPSIN D; CHROMOSOME 1 OPEN READING FRAME 8 PROTEIN; EARLY ENDOSOME ANTIGEN 1; FIBRIN; FIBRIN BETA; GENE PRODUCT; GENERAL TRANSCRIPTION FACTOR; GENERAL TRANSCRIPTION FACTOR II H; HEAT SHOCK PROTEIN 27; IMMUNOGLOBULIN; LIPOCORTIN 2; LLDBP PROTEIN; MUSCLE PROTEIN; PKM2 PROTEIN; PROTEASOME; PROTEIN CDC42; PYRUVATE KINASE; SMOOTH MUSCLE PROTEIN; SYNTAXIN BINDING PROTEIN; TRANGELIN; TROPOMYOSIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 7; UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; CHINA; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC VALUE; DISEASE MARKER; EPITHELIUM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; ETHNIC GROUP; ETHNICITY; FEMALE; GENDER; HAN; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAZAKH; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; UYGUR;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CATHEPSIN D; CHINA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESOPHAGEAL NEOPLASMS; ETHNIC GROUPS; FEMALE; HUMANS; MALE; NEOPLASM PROTEINS; PROTEOMICS; PYRUVATE KINASE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 80052516312     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0586-0     Document Type: Article

References (26)

1. Lambert R, Hainaut P (2007) The multi disciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol 21:921-945
2. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW et al (2005) Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 113:456-463 (Pubitemid 40038715)
3. Zhang YM (1988) The distribution of esophageal cancer in Xinjiang. Acta Acad Med Xinjiang 11:139-144
4. Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N et al (1996) Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res 56:2776-2780 (Pubitemid 26175737)
5. Kwong KF (2005) Molecular biology of esophageal cancer in the genomics era. Surg Clin North Am 85:539-553 (Pubitemid 40779374)
6. Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349:2241-2252 (Pubitemid 37485141)
7. Zhang Q, Wang J, Dong R, Yang S, Zheng S (2010) Identification of novel serum biomarkers in child nephroblastoma using proteomics technology. Mol Biol Rep. doi:10.1007/s11033-010- 0149-4
8. Uemura N, Nakanishi Y, Kato H, Saito S, Nagino M, Hirohashi S et al (2009) Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer 124: 2106-2115
9. Looi ML, Karsani SA, Rahman MA, Dali AZ, Ali SA, Ngah WZ et al (2009) Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma. J Biosci 34:917-925
10. Liu W, Ma Y, Huang L, Peng J, Zhang P, Zhang H et al (2010) Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis. Mol Biol Rep 37:3207-3216
11. Borutinskaite VV, Magnusson KE, Navakauskiene R (2010) α-Dystrobrevin distribution and association with other proteins in human promyelocytic NB4 cells treated for granulocytic differentiation. Mol Biol Rep. doi:10.1007/s11033-010-9965-9
12. Zupanc MM, Wellbrock UM, Zupanc GK (2006) Proteome analysis identifies novel protein candidates involved in regeneration of the cerebellum of teleost fish. Proteomics 6:677-696 (Pubitemid 43208047)
13. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E (2005) Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15:300-308 (Pubitemid 41058775)
14. Wechsel HW, Petri E, Bichler KH, Feil G (1999) Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK). Anticancer Res 19:2583-2590 (Pubitemid 29392417)
15. Schneider J, Neu K, Grimm H, Velcovsky HG, Weisse G, Eigenbrodt E (2002) Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring. Anticancer Res 22:311-318 (Pubitemid 34475318)
16. Kaura B, Bagga R, Patel FD (2004) Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma. J Obstet Gynaecol Res 30:193-196 (Pubitemid 38855821)
17. Schneider J, Schulze G (2003) Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. Anticancer Res 23:5089-5093 (Pubitemid 38182129)
18. Hardt PD, Toepler M, Ngoumou B, Rupp J, Kloer HU (2003) Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls. Anticancer Res 23:851-853 (Pubitemid 36750884)
19. Schulze G (2000) The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer. Anticancer Res 20:4961-4964 (Pubitemid 32319059)
20. Koss K, Harrison RF, Gregory J, Darnton SJ, Anderson MR, Jankowski JA (2004) The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus. J Clin Pathol 57:1156-1159 (Pubitemid 39486520)
21. Allgayer H, Heiss MM, Schildberg FW (1997) Prognostic factors in gastric cancer. Br J Surg 84:1651-1664 (Pubitemid 27519590)
22. Schwartz MK (1995) Tissue cathepsins as tumor markers. Clin Chim Acta 237:67-78
23. Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM, Zacharias W (2000) Variable expression of cathepsin B and D correlates with high invasive and metastatic phenotype of oral cancer. Hum Pathol 31:931-937
24. Allgayer H, Babic R, Grutzner KU, Beyer BC, Tarabichi A, Schildberg FW et al (1997) An immunohistochemical assessment of cathepsin D in gastric carcinoma. Cancer 80:179-187 (Pubitemid 27282308)
25. Breton J, Gage MC, Hay AW, Keen JN, Wild CP, Donnellan C et al (2008) Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma. J Proteome Res 7:1953-1962
26. Ikeguchi M, Sakatani T, Ueta T, Fukuda K, Oka S, Hisamitsu K et al (2002) Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma. J Clin Pathol 55:121-126 (Pubitemid 34123913)